Latest News On Trump Administration

Latest California Healthline Stories

Podcast: KHN’s ‘What The Health?’ ‘Medicare-For-All’ Debate: Who’s Going To Pay

Margot Sanger-Katz of The New York Times, Paige Winfield Cunningham of The Washington Post and Jennifer Haberkorn of the Los Angeles Times join KHN’s Julie Rovner to discuss the new “Medicare-for-all” bill introduced by House Democrats, the grilling of pharmaceutical company CEOs by a Senate committee and new Trump administration rules that take aim at Planned Parenthood. Plus, Rovner interviews KHN’s Julie Appleby about the latest “Bill of the Month” installment.

Despite 1991 Ruling, Foes Of New Family Planning Rules See Law On Their Side

Lawyers seeking to block the Trump administration’s decision to alter rules for the Title X family planning program say their efforts will not be stymied by the Supreme Court’s approval of similar rules 28 years ago. They point to new protections enacted in the Affordable Care Act and language in funding bills that shifts the legal calculus.

In Florida, Drug Importation From Canada Finds New Champions, Old Snags

The state’s governor said the plan has the full support of the White House. But the Trump administration was noncommittal about whether allowing states to buy and import cheaper drugs from up north could be the answer to the nation’s drug-pricing problem.

HHS Finalizes Rule Seeking To Expel Planned Parenthood From Family Planning Program

The new regulation would drop previous rules for the Title X program requiring that women with unintended pregnancies be told about all options, including abortion. One-quarter of the women potentially affected by the changes live in California, and the state’s attorney general, Xavier Becerra, said he is prepared to sue.

Podcast: KHN’s ‘What The Health?’ How Safe Are Your Supplements?

Alice Ollstein of Politico, Kimberly Leonard of the Washington Examiner and Anna Edney of Bloomberg News join KHN’s Julie Rovner to discuss the latest national health spending estimates, another FDA crackdown on dietary supplements and lawsuits between insurers and the federal government that could result in a windfall for consumers.